Is neoadjuvant therapy the answer to adenocarcinoma of the esophagus?

被引：9
|
作者：
Burak, WE
机构：
[1] Ohio State Univ, Div Surg Oncol, Dept Surg, Arthur G James Canc Hosp, Columbus, OH 43210 USA
[2] Ohio State Univ, Richard J Solove Res Inst, Columbus, OH 43210 USA
来源：
AMERICAN JOURNAL OF SURGERY | 2003年 / 186卷 / 03期
关键词：
adenocarcinoma; esophagus; neoadjuvant therapy;
D O I：
10.1016/S0002-9610(03)00222-8
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
The conflicting results of randomized studies have led to confusion over the proper management of patients with esophageal adenocarcinoma. Although there is no firm evidence that neoadjuvant chemoradiation improves survival, because of the shortcomings of these trials, this method of treatment is practiced at many centers. Without the results of another multiinstitutional randomized trial, the true answer may never be known. (C) 2003 Excerpta Medica, Inc. All rights reserved.
引用
收藏
页码：296 / 300
页数：5
相关论文
共 50 条
  • [41] Clinical biology and surgical therapy of intramucosal adenocarcinoma of the esophagus
    Oh, Daniel S.
    Hagen, Jeffrey A.
    T Chandrasoma, Parakrama
    Dunst, Christy M.
    DeMeester, Steven R.
    Alavi, Mohammad
    Bremner, Cedric G.
    Lipham, John
    Rizzetto, Christian
    Cote, Richard
    DeMeester, Tom R.
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2006, 203 (02) : 152 - 161
  • [42] Clinical and endoscopic response to neoadjuvant therapy for carcinoma of the esophagus.
    Bowrey, DJ
    Clark, GWB
    Roberts, SA
    Maughan, TS
    Hawthorne, AB
    Carey, PD
    GASTROENTEROLOGY, 1998, 114 (04) : A568 - A568
  • [43] Neoadjuvant Chemoradiation Therapy in Borderline Resectable Pancreatic Adenocarcinoma
    Shafi, S.
    Kaubisch, A.
    PANCREAS, 2015, 44 (08) : 1413 - 1413
  • [44] Prediction of Response To Neoadjuvant Therapy in Rectal and Breast Adenocarcinoma
    Feeney, G.
    Ryan, E.
    Waldron, R.
    Miller, N.
    Joyce, M.
    Kerin, M. J.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2020, 189 (SUPPL 5) : S135 - S135
  • [45] Does neoadjuvant therapy improve survival in pancreatic adenocarcinoma?
    Chopra, Asmita
    Paniccia, Alessandro
    HEPATOBILIARY SURGERY AND NUTRITION, 2021, 10 (05) : 728 - 730
  • [46] Neoadjuvant Therapy for Resectable and Borderline Resectable Adenocarcinoma of the Pancreas
    Wolff, Robert A.
    CURRENT DRUG TARGETS, 2012, 13 (06) : 781 - 788
  • [47] Trends in the utilization of neoadjuvant therapy for pancreatic ductal adenocarcinoma
    Brown, Zachary J.
    Cloyd, Jordan M.
    JOURNAL OF SURGICAL ONCOLOGY, 2021, 123 (06) : 1432 - 1440
  • [48] Effect of neoadjuvant therapy in patients with resected pancreatic adenocarcinoma
    LoConte, Noelle K.
    Mohammed, Tabraiz Aijaz
    Winslow, Emily
    Neuman, Heather B.
    Smith, Maureen
    Allen, Glenn
    Schmacher, Jessica
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (03)
  • [49] Neoadjuvant Therapy for Duodenal and Ampullary Adenocarcinoma: A Systematic Review
    Zhang, Chunmeng
    Lizalek, Jason M.
    Dougherty, Collin
    Westmark, Danielle M.
    Klute, Kelsey A.
    Reames, Bradley N.
    ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (02) : 1347 - 1357
  • [50] Value of Neoadjuvant Radiation Therapy in the Management of Pancreatic Adenocarcinoma
    Hall, William A.
    Dawson, Laura A.
    Hong, Theodore S.
    Palta, Manisha
    Herman, Joseph M.
    Evans, Douglas B.
    Tsai, Susan
    Ferrone, Cristina R.
    B. Fleming, Jason
    Chang, Daniel T.
    Crane, Christopher
    Koong, Albert C.
    Oar, Andrew
    Parikh, Parag
    Erickson, Beth
    Hoffe, Sarah
    Goodman, Karyn A.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (34) : 3773 - +
12345